Nantahala Capital Management, LLC Hookipa Pharma Inc. Transaction History

Nantahala Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.26 - $2.52 $596,693 - $1.19 Million	-473,566 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $50,845 - $129,622	-21,822 Reduced 4.41%	473,566 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $98,480 - $156,332	-16,720 Reduced 3.26%	495,388 $2.92 Million
Q2 2021 Aug 16, 2021	SELL	$9.16 - $19.51 $3.55 Million - $7.57 Million	-387,892 Reduced 43.1%	512,108 $4.69 Million
Q1 2021 May 14, 2021	BUY	$10.64 - $14.7 $9.58 Million - $13.2 Million	900,000 New	900,000 $12.1 Million

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $139M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.